Pulmonary malignancies in the immunocompromised patient

Respiration

Volumn 66, Issue 4, 1999, Pages 289-309

  Cadranel, Jacques ^a,b   Naccache, Jean Marc ^a   Wislez, Marie ^a   Mayaud, Charles ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; HODGKIN DISEASE; HUMAN; IMMUNE DEFICIENCY; KAPOSI SARCOMA; LUNG CANCER; LUNG CARCINOMA; NONHODGKIN LYMPHOMA; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SURVIVAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CARCINOMA, BRONCHOGENIC; HODGKIN DISEASE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSION; LUNG NEOPLASMS; LYMPHOMA, AIDS-RELATED; LYMPHOMA, NON-HODGKIN; SARCOMA, KAPOSI; TRANSPLANTATION IMMUNOLOGY;

EID: 0032780637     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000029397     Document Type: Review

References (231)

1. Martin R, Hood A, Farmer E: Kaposi sarcoma. Medicine 1993;72:245-258.
2. Mitchell D, Miller R: AIDS and the lung: Update 1992. 2. Recent developments in the management of the pulmonary complications of HIV disease. Thorax 1992;47:381-390.
3. Tappero J, Conant M, Wolfe S, Berger T: Kaposi's sarcoma: Epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy. J Am Acad Dermatol 1993;28: 371-395.
4. Schulz TF, Boshoff CH, Weiss RA: HIV infection and neoplasia. Lancet 1996;348:587-591.
5. Smith C, Lilly S, Mann KP, Livingston E, Myers S, Lyerly HK, Miralles GD: AIDS-related malignancies. Ann Med 1998;30:323-344.
6. Goedert JJ, Cote TR, Virgo P, Scoppa SM, Kingma DW, Gail MH, Jaffe ES, Biggar RJ: Spectrum of AIDS-associated malignant disorders. Lancet 1998;351:1833-1839.
7. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans: Human immunodeficiency viruses and human T-cell lymphotropic viruses. IARC Monogr Eval Carcinog Risks Hum 1996;67.
8. Safai B, Schwartz J: Kaposi's sarcoma and the acquired immunodeficiency syndrome; in De Vitta V, Hellman S, Rosenberg A (eds): AIDS -Etiology, Diagnosis and Prevention. Philadelphia, Lippincott, 1992, pp 209-223.
9. Montagnino G, Lorca E, Tarantino A, Bencini P, Aroldi A, Cesana B, Braga M, Lonati F, Ponticelli C: Cancer incidence in 854 kidney transplant recipients from a single institution: Comparison with normal population and with patients under dialytic treatment. Clin Transplant 1996;10:461-469.
10. Mihalov ML, Gattuso P, Abraham K, Holmes EW, Reddy V: Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center. Clin Transplant 1996;10:248-255.
11. Goldstein DJ, Williams DL, Oz MC, Weinberg AD, Rose EA, Michler RE: De novo solid malignancies after cardiac transplantation. Ann Thorac Surg 1995;60:1783-1789.
12. Alexander JW, First MR, Hariharan S, Penn I, Schroeder T, Ryckman F, Munda R, Bhat G, Bolce R: Recent contributions to transplantation at the University of Cincinnati. Clin Transplant 1991:159-178.
13. Farge D: Kaposi's sarcoma in organ transplant recipients. The Collaborative Transplantation Research Group of Ile de France. Eur J Med 1993;2:339-343.
14. Sachsenberg-Studer EM, Dobrynski N, Sheldon J, Schulz TF, Pechere M, Nador RG, Spiliopoulos A, Nicod L, Saurat JH: Human herpes-virus 8 seropositive patient with skin and graft Kaposi's sarcoma after lung transplantation. J Am Acad Dermatol 1999;40:308-311.
15. Sleiman C, Mal H, Roue C, Groussard O, Baldeyrou P, Olivier P, Fournier M, Pariente R: Bronchial Kaposi's sarcoma after single lung transplantation. Eur Respir J 1997;10:1181-1183.
16. Shaheen MH, al-Sulaiman MH, Ramprasad KS, al-Khader AA: Kaposi's sarcoma in renal transplant recipients. Ann Transplant 1997;2: 49-58.
17. Ecder ST, Sever MS, Yildiz A, Turkmen A, Kayacan SM, Kilicaslan I, Kocak T, Eldegez U: Kaposi's sarcoma after renal transplantation in Turkey. Clin Transplant 1998;12:472-475.
18. Margolius L, Stein M, Spencer D, Bezwoda WR: Kaposi's sarcoma in renal transplant recipients. Experience at Johannesburg Hospital, 1966-1989. S Afr Med J 1994;84:16-17.
19. Besnard V, Euvrard S, Kanitakis J, Mion F, Boillot O, Frances C, Faure M, Claudy A: Kaposi's sarcoma after liver transplantation. Dermatology 1996;193:100-104.
20. Szende B, Toth A, Perner F, Nagy K, Takacs K: Clinicopathologic aspects of 8 Kaposi's sarcomas among 1009 renal transplant patients. Gen Diagn Pathol 1997;143:209-213.
21. Safai B, Johnson K, Myskowski P, Al E: The natural history of Kaposi's sarcoma in the acquired immunodeficiency syndrome. Ann Intern Med 1985;103:744-750.
22. Qunibi W, Akhtar M, Sheth K, Ginn HE, Al-Furayh O, DeVol EB, Taher S: Kaposi's sarcoma: The most common tumor after renal transplantation in Saudi Arabia. Am J Med 1988; 84:225-232.
23. Pollack M, Safai B, Dupont B: HLA-DR5 and DR2 are susceptibility factors for acquired immunodeficiency syndrome with Kaposi's sarcoma in different ethnic subpopulations. Dis Markers 1983;1:135-139.
24. Gill PS, Lunardi-Ishkandar Y, Louie S. Tulpule A, ZhengT, Espina BM, Besnier JM, Hermans P, Levine AM, Bryant JL, Gallo RC: The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma. N Engl J Med 1996;335:1261-1269.
25. Cathomas G, Tamm M, McGandy CE, Perruchoud AP, Mihatsch MJ, Dalquen P: Detection of herpesvirus-like DNA in the bronchoalveolar lavage fluid of patients with pulmonary Kaposi's sarcoma. Eur Respir J 1996;9:1743-1746.
26. Tamm M, Reichenberger F, McGandy CE, Stalder A, Tietz A, Dalquen P, Perruchoud AP, Cathomas G: Diagnosis of pulmonary Kaposi's sarcoma by detection of human herpes virus 8 in bronchoalveolar lavage. Am J Respir Crit Care Med 1998;157:458-463.
27. Jones JL, Hanson DL, Chu SY, Ward JW, Jaffe HW: AIDS-associated Kaposi's sarcoma. Science 1995;267:1078-1079.
28. Mocroft A, Youle M, Gazzard B, Morcinek J, Halai R, Phillips AN: Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group. AIDS 1996;10:1101-1105.
29. Costagliola D, Mary-Krause M: Can antiviral agents decrease the occurrence of Kaposi's sarcoma? Clinical Epidemiology Group from Centres d'Information et de Soins de l'Immunodéficience Humaine (letter). Lancet 1995; 346:578.
30. Vogel J, Hinrichs S, Reynolds R: The HIV tat gene induced dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature 1988; 335:606-611.
31. Ensoli B, Barillari G, Salahuddin H: Tat protein of HIV1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 1990;345:84.
32. Nakamura S, Salahuddin S, Biberferld P: Kaposi's sarcoma cells: Long-term culture with growth factor from retrovirus infected CD4+ T cells. Science 1988;242:426-430.
33. Gearing D, Comeau M, Friend D: The 11-6 signal transducer, apl 30: An oncostatin receptor and affinity converter for the LIf receptor. Science 1992;255.
34. Chandran Nair B, De Vico A, Nakamura S: Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M. Science 1992;255:1430-1432.
35. Ensoli B, Nakamura S, Biberfeld P: AIDS-Kaposi's sarcoma derived-cells express cytokines as autocrine and paracrine growth effects. Science 1989;243:223-226.
36. White D, Matthay R: Noninfectious pulmonary complications of infection with the human immunodeficiency virus. Am Rev Respir Dis 1989;140:1763-1787.
37. Pozniak A, Latif A, Neill P, Houston S, Chen K: Pulmonary Kaposi's sarcoma in Africa. Thorax 1992;47:730-733.
38. De Truchis P, Cadranel J, Touboul J, Denis M, Fouret P, Roux P: Frequence respective et aspects radiocliniques de 150 pneumopathies observées chez 125 malades infectés par le virus de l'immunodéficience humaine. Presse Med 1988;17:781-785.
39. Murray J, Felton C, Garay S, Gottlieb M, Hopewell P, Slower D: Pulmonary complications of the acquired immunodeficiency syndrome. N Engl J Med 1984;21:1682-1688.
40. Pitkin A, Grant A, Foley N, Miller R: Changing patterns of respiratory disease in HIV positive patients in a referral centre in the United Kingdom between 1986-7 and 1990-1. Thorax 1993;48:204-207.
41. Stover D, White D, Romano P, Gellene R, Robesoin W: Spectrum of pulmonary disease associated with acquired immune deficiency syndrome. Am J Med 1985;78:459-467.
42. Mitchell D, McCarty M, Fleming J, Moss F: Bronchopulmonary Kaposi's sarcoma in patients with AIDS. Thorax 1992;47:726-729.
43. Cadranel J, Chouaid C, Denis M, Lebeau B, Akoun G, Mayaud C: Causes of pleural effusion in 75 HIV-infected patients. Chest 1993; 104:655.
44. Garay S, Belenko M, Fazzini E, Schinella R: Pulmonary manifestations of Kaposi's sarcoma. Chest 1987;91:39-43.
45. Gill P, Akil B, Colletti P, Rarick M, Loureiro C, Berstein-Singer M: Pulmonary Kaposi's sarcoma: Clinical findings and results of therapy. Am J Med 1989;87:57-61.
46. Ognibene F, Steis R, Macher A, Liotta L, Gelma E, Pass H: Kaposi's sarcoma causing pulmonary infiltrates and respiratory failure in the acquired immunodeficiency syndrome. Ann Intern Med 1985;102:471-475.
47. Allier I, Cadranel J, Parquin F, Denis M, Lepen De Ven C, Antoine M, Mayaud C, Akoun G: Pleurésies chez les malades infectés par le VIH. Presse Méd 1991;20:1931-1934.
48. Cadranel J, Kammoun S, Chevret S, Parrot A, Denis M, Winter C, Rozenbaum W, Akoun G, Mayaud C: Results of chemotherapy in 30 AIDS patients with symptomatic pulmonary Kaposi's sarcoma. Thorax 1994;49:101-103.
49. Zibrak J, Silvestri R, Costello P, Marlink R, Jensen W, Robins A: Bronchoscopic and radiologic features of Kaposi's sarcoma involving the respiratory system. Chest 1986;90:476-479.
50. Penn I: Incidence and treatment of neoplasia after transplantation. J Heart Lung Transplant 1993;12:5328-5336.
51. Meduri G, Sover D, Lee M, Myskowski P, Caravelli J, Zaman M: Pulmonary Kaposi's sarcoma in the acquired immune deficiency syndrome. Am J Med 1986;81:11-18.
52. O'Brien R, Cohn D: Serosanguineous pleural effusions in AIDS-associated Kaposi's sarcoma. Chest 1989;96:460-466.
53. Fouret P, Touboul J, Mayaud C, Akoun G, Roland J: Pulmonary Kaposi's sarcoma in patients with acquired immune deficiency syndrome: A clinicopathological study. Thorax 1987;42:262-268.
54. Miller R, Tomlinson M, Cottrill C, Donald J, Spittle M, Semple S: Bronchopulmonary Kaposi's sarcoma in patients with AIDS. Thorax 1992;47:721-725.
55. De Rosa G, Bara E, Guarino M, Gentile R: Multicentric Castelman's disease in association with Kaposi's sarcoma. Appl Pathol 1989;7: 105-110.
56. Oksenhendler E, Duarte M, Soulier J, Cacoub P, Welker Y, Cadranel J, Cazals-Hatem D, Autran B, Clauvel J, Raphael M: Multicentric Castelman's disease in HIV infection: A clinical and pathological study of 20 patients. AIDS 1996;10:61-67.
57. Khalil A, Carette MF, Cadranel J, Mayaud C, Bigot J: Intrathoracic Kaposi's sarcoma: CT scan findings. Chest 1995;108:1622-1626.
58. Sivit C, Schwartz A, Rockoff S: Kaposi's sarcoma of the lung in AIDS: Radiologic-pathologic analysis. AJR 1987;148:25-28.
59. Naidich D, Tarras M, Garay S, Bimbaum B, Rybak B, Schinella R: Kaposi's sarcoma; CT-radiographic correlation. Chest 1989;96:723-728.
60. Padovani B, Sedat J, Mouroux J, Diaine B, Chanalet S, Thyss A, Hofman P, Lepidi X, Bruneton J: Sarcome de Kaposi pulmonaire chez les patients atteints du syndrome d'immunodéficience acquise. Apport de la radiographie du thorax et du scanner. J Radiol 1993;74:467-472.
61. Rouffiat J, Najmark P, Sournia V: Les images radiologiques du sarcome de Kaposi. Ann Radiol 1987;30:324-329.
62. Hartman T, Primack S, Moller N, Staples C: Diagnosis of thoracic complications in AIDS: Accuracy of CT. AJR 1994;162:547-553.
63. Wolff S, Kuhlman J, Fishman E: Thoracic Kaposi's sarcoma in AIDS: CT findings. J Comput Assist Tomogr 1993;17:60-62.
64. Gill P, Rarick M, McCutchan J, Slater M, Parker B, Muchmore E: Systemic treatment of AIDS-related Kaposi's sarcoma: results of a randomized trial. Am J Med 1991;90.
65. Khan GA, Klapper P: Pulmonary haemorrhage following renal transplantation. Thorax 1995; 50:98-99.
66. Benfield TL, Dodt KK, Lundgren JD: Human herpes virus-8 DNA in bronchoalveolar lavage samples from patients with AIDS-associated pulmonary Kaposi's sarcoma. Scand J Infect Dis 1997;29:13-16.
67. Beck JM: Pleural disease in patients with acquired immune deficiency syndrome. Clin Chest Med 1998;19:341-349.
68. Cadranel J, Rosso J, Mayaud C, Meignan M: Radionuclide imaging in pulmonary complications of HIV infection; in Diot P. Baulieu J, Lemarie E (eds): Nuclear Medicine and Lung Diseases: Berlin, Springer, 1993, pp 95-104.
69. Mitchell D, Fleming J, Pinching A, Harris J, Moss F, Veale D, Shaw R: Pulmonary function in human immunodeficiency virus infection. A prospective 18-month study of serial lung function in 474 patients. Am Rev Respir Dis 1992; 146:745-751.
70. Lee V, Fuller J, O'Brien M: Pulmonary Kaposi's sarcoma in patients with AIDS: Scintigraphic diagnosis with sequential thallium and gallium scanning. Radiology 1991;180:409-412.
71. Aboulafia DM: Regression of acquired immunodeficiency syndrome-related pulmonary Kaposi's sarcoma after highly active antiretroviral therapy. Mayo Clin Proc 1998;73:439-443.
72. Jung C, Bogner JR, Goebel F: Resolution of severe Kaposi's sarcoma after initiation of anti-retroviral triple therapy. Eur J Med Res 1998; 3:439-442.
73. Gelmann E, Longo D, Lane H, Fauci A, Masur H, Wesley M: Combinaison chemotherapy of disseminated Kaposi's sarcoma in patients with the acquired immune deficiency syndrome. Am J Med 1987;82:456-462.
74. Caumes E, Guermonprez G, Katlama C: AIDS associated mucocutaneous Kaposi's sarcoma treated with bleomycin. AIDS 1992;6:1483-1487.
75. Gill P, Rarick M, Espina B, Loureiro C, Bernstein-Singer M, Akil B: Advanced acquired immune deficiency syndrome-related Kaposi's sarcoma. Cancer 1990:1074-1078.
76. Laubenstein L, Krigel R, Odajnyk C. Hymes K, Friedman-Kien A, Wernz J: Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastin. J Clin Oncol 1984;2:1115-1120.
77. Welles L, Saville MW, Lietzau J, Pluda JM, Wyvill KM, Feuerstein I, Figg WD, Lush R, Odom J, Wilson WH, Fajardo MT, Humphrey RW, Feigal E, Tuck D, Steinberg SM, Broder S, Yarchoan R: Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma. J Clin Oncol 1998;16:1112-1121.
78. Gill PS, Wernz J, Scadden DT, Cohen P, Mukwaya GM, von Roenn JH, Jacobs M, Kempin S, Silverberg I, Gonzales G, Rarick MU, Myers AM, Shepherd F, Sawka C, Pike MC, Ross ME: Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma. J Clin Oncol 1996;14:2353-2364.
79. Levine AM: AIDS-related lymphoma: Clinical aspects; in Broders MT, Bolognesi JD (eds): Textbook of AIDS Medicine. Baltimore, Pine, 1994, vol 29, p 465.
80. Knowles DM: AIDS-associated malignant lymphoma; in Broders MT, Bolognesi JD (eds): Textbook of AIDS Medicine. Baltimore, Pine, 1994, vol 28, p 431.
81. Ray P, Antoine M, Mary-Krause M, Lebrette MG, Wislez M, Duvivier C, Meyohas MC, Girard PM, Mayaud C, Cadranel J: AIDS-related primary pulmonary lymphoma. Am J Respir Crit Care Med 1998;158:1221-1229.
82. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM: Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas (see comments). N Engl J Med 1995;332:1186-1191.
83. Cohen JI: Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency. Medicine 1991;70:137-160.
84. Ballerini P, Gaidano G, Gong JZ, Tassi V, Saglio G, Knowles DM, Dalla-Favera R: Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Blood 1993;81:166-176.
85. Irwin DH, Kaplan LD: Pulmonary manifestations of acquired immunodeficiency syndrome-associated malignancies. Semin Respir Infect 1993;8:139-148.
86. Sider L, Weiss AJ, Smith MD, VonRoenn JH, Glassroth J: Varied appearance of AIDS-related lymphoma in the chest. Radiology 1989; 171:629-632.
87. Eisner MD, Kaplan LD, Herndier B, Stulbarg MS: The pulmonary manifestations of AIDS-related non-Hodgkin's lymphoma. Chest 1996;110:729-736.
88. Tirelli U, Errante D, Oksenhendler E, Spina M, Vaccher E, Serraino D, Gastaldi R, Repetto L, Rizzardini G, Carbone A, et al: Prospective study with combined low-dose chemotherapy and zidovudine in 37 patients with poor-prognosis AIDS-related non-Hodgkin's lymphoma. French-Italian Cooperative Study Group. Ann Oncol 1992;3:843-847.
89. White D SD: Pulmonay complications of HIV infection. Clin Chest Med 1996;4:755-761.
90. Chechani V, Allam AA, Kamholz SL: Pulmonary non-Hodgkin's lymphoma mimicking infection. Respi rMed 1990;84:401-405.
91. Polish LB, Cohn DL, Ryder JW, Myers AM, O'Brien RF: Pulmonary non-Hodgkin's lymphoma in AIDS. Chest 1989;96:1321-1326.
92. Bigonzi F, Touboul JL, Fouret P, Denis M, Mayaud C, Akoun G: Isolated pulmonary lymphoma in a patient with acquired immunodeficiency syndrome. Rev Pneumol Clin 1987;43:216-218.
93. Chaouat A, Fraisse P, Kessler R, Lang JM, Weitzenblum E: A life-threatening tracheal localization of lymphoma in a patient with AIDS. Chest 1993;103:1297-1299.
94. Colebunders R, Mertens V, Blot K, Neetens I, Van Marck E, Batungwanayo J, Taelman H: Pulmonary T-cell lymphoma in a patient with the acquired immunodeficiency syndrome (letter). Clin Infect Dis 1993;16:188.
95. Carignan S, Staples CA, Muller NL: Intrathoracic lymphoproliferative disorders in the immunocompromised patient: CT findings. Radiology 1995;197:53-58.
96. Heitzman ER: Pulmonary neoplastic and lymphoproliferative disease in AIDS: A review. Radiology 1990;177:347-351.
97. Ko AH, Thomas DL, Gallant JE: Non-Hodgkin's lymphoma and Kaposi's sarcoma causing cavitary lung lesions in a patient with AIDS: An HIV-associated collision tumor (letter). AIDS 1995;9:1195-1197.
98. Poelzleitner D, Huebsch P, Mayerhofer S, Chott A, Zielinski C: Primary pulmonary lymphoma in a patient with the acquired immune deficiency syndrome. Thorax 1989;44: 438-439.
99. Judson MA, Sahn SA: Endobronchial lesions in HIV-infected individuals. Chest 1994;105: 1314-1323.
100. Baselga J, Krown SE, Telzak EE, Filippa DA, Straus DJ: Acquired immune deficiency syndrome-related pulmonary non-Hodgkin lymphoma regressing after zidovudine therapy. Cancer 1993;71:2332-2334.
101. Nasr SA, Brynes RK, Garrison CP, Chan WC: Peripheral T-cell lymphoma in a patient with acquired immune deficiency syndrome. Cancer 1988;61:947-951.
102. Forbes AD, Marchioro TL, Schmidt RA, Wood B, Verrier ED: Acquired immunodeficiency syndrome-related lymphoma of the lung presenting as empyema thoracis. Ann Thorac Surg 1994;57:216-219.
103. Sternlieb J, Mintzer D, Kwa D, Gluckman S: Peripheral T-cell lymphoma in a patient with the acquired immunodeficiency syndrome. Am J Med 1988;85:445.
104. Kohler CA, Gonzalez-Ayala E, Rowley P, Malamud F, Verghese A: Primary pulmonary T-cell lymphoma associated with AIDS: The syndrome of the indolent pulmonary mass lesion. Am J Med 1995;99:324-326.
105. Mittal K, Neri A, Feiner H, Schinella R, Alfonso F: Lymphomatoid granulomatosis in the acquired immunodeficiency syndrome. Evidence of Epstein-Barr virus infection and B-cell clonal selection without myc rearrangement. Cancer 1990;65:1345-1349.
106. Teruya-Feldstein J, Temeck BK, Sloas MM, Kingma DW, Raffeld M, Pass HI, Mueller B, Jaffe ES: Pulmonary malignant lymphoma of mucosa-associated lymphoid tissue (MALT) arising in a pediatric HIV-positive patient. Am J Surg Pathol 1995;19:357-363.
107. Cordier JF, Chailleux E, Lauque D, Reynaud-Gaubert M, Dietemann-Molard A, Dalphin JC, Blanc-Jouvan F, Loire R: Primary pulmonary lymphomas. A clinical study of 70 cases in nonimmunocompromised patients. Chest 1993;103:201-208.
108. Stansfeld AG, Diebold J, Noel H, Kapanci Y, Rilke F, Kelenyi G, Sundstrom C, Lennert K, van Unnik JA, Mioduszewska O, et al: Updated Kiel classification for lymphomas (letter). Lancet 1988;i:292-293.
109. Hamilton-Dutoit SJ, Raphael M, Audouin J, Diebold J, Lisse I, Pedersen C, Oksenhendler E, Marelle L, Pallesen G: In situ demonstration of Epstein-Barr virus small RNAs (EBER 1) in acquired immunodeficiency syndrome-related lymphomas: Correlation with tumor morphology and primary site. Blood 1993;82: 619-624.
110. Nador RG, Cesarman E, Chadburn A, Dawson DB, Ansari MQ, Sald J, Knowles DM: Primary effusion lymphoma: A distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 1996;88:645-656.
111. Light RW, Hamm H: Pleural disease and acquired immune deficiency syndrome. Eur RespirJ 1997;10:2638-2643.
112. Ansari MQ, Dawson DB, Nador R, Rutherford C, Schneider NR, Latimer MJ, Picker L, Knowles DM, McKenna RW: Primary body cavity-based AIDS-related lymphomas (see comments). Am J Clin Pathol 1996;105:221-229.
113. Kaplan LD, Abrams DI, Feigal E, McGrath M, Kahn J, Neville P, Ziegler J, Volberding PA: AIDS-associated non-Hodgkin's lymphoma in San Francisco. Jama 1989;261:719-724.
114. Gill PS, Levine AM, Krailo M, Rarick MU, Loureiro C, Deyton L, Meyer P, Rasheed S: AIDS-related malignant lymphoma: Results of prospective treatment trials. J Clin Oncol 1987;5:1322-1328.
115. Sawka CA, Shepherd FA, Brandwein J, Burkes RL, Sutton DM, Warner E: Treatment of AIDS-related non-Hodgkin's lymphoma with a twelve week chemotherapy program. Leuk Lymphoma 1992;8:213-220.
116. Levine AM, Wernz JC, Kaplan L, Rodman N, Cohen P, Metroka C, Bennett JM, Rarick MU, Walsh C, Kahn J, et al: Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma. A prospective multi-institutional trial. JAMA 1991;266:84-88.
117. Kaplan LD, Straus DJ, Testa MA, Von Roenn J, Dezube BJ, Cooley TP, Herndier B, Northfelt DW, Huang J, Tulpule A, Levine AM: Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. N Engl J Med 1997;336: 1641-1648.
118. Matsushima Y, Kanzawa F, Hoshi A, Shimizu E, Nomori H, Sasaki Y, Saijo N: Time-schedule dependency of the inhibiting activity of various anticancer drugs in the clonogenic assay. Cancer Chemother Pharmacol 1985;14:104-107.
119. Sparano JA, Wiernik PH, Leaf A, Dutcher JP: Infusional cyclophosphamide, doxorubicin, and etoposide in relapsed and resistant non-Hodgkin's lymphoma: Evidence for a schedule-dependent effect favoringinfusional administration of chemotherapy. J Clin Oncol 1993;11:1071-1079.
120. Mazza P, Bocchia M, Tumietto F, Costigliola P, Coronado O, Bandini G, Conte R, Ricchi E, Vianelli N, Raise E, et al: Recombinant interleukin-2 (rIL-2) in acquiredimmune deficiency syndrome (AIDS): Preliminary report in patients with lymphoma associated with HIV infection. Eur J Haematol 1992;49: 1-6.
121. Bernstein ZP, Porter MM, Gould M, Lipman B, Bluman EM, Stewart CC, Hewitt RG, Fyfe G, Poiesz B, Caligiuri MA: Prolonged administration of low-dose interleukin-2 in human immunodeficiency virus-associated malignancy results in selective expansion of innate immune effectors without significant clinical toxicity. Blood 1995;86:3287-3294.
122. Levine AM, Sullivan-Halley J, Pike MC, Rarick MU, Loureiro C, Bernstein-Singer M, Willson E, Brynes R, Parker J, Rasheed S, et al: Human immunodeficiency virus-related lymphoma. Prognostic factors predictive of survival. Cancer 1991;68:2466-2472.
123. Kaplan LD, Shiramizu B, Herndier B, Hahn J, Meeker TC, Ng V, Volberding PA, McGrath MS: Influence of molecular characteristics on clinical outcome in human immunodeficiency virus-associated non-Hodgkin's lymphoma: Identification of a subgroup with favorable clinical outcome. Blood 1995;85: 1727-1735.
124. Knowles DM, Chamulak GA, Subar M, Burke JS, Dugan M, Wernz J, Slywotzky C, Pelicci G, Dalla-Favera R, Raphael B: Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). The New York University Medical Center experiencewith 105 patients (1981-1986). Ann Intern Med 1988;108:744-753.
125. Bermudez MA, Grant KM, Rodvien R, Mendes F: Non-Hodgkin's lymphoma in a population with or at risk for acquired immunodeficiency syndrome: Indications for intensive chemotherapy. Am J Med 1989;86:71-76.
126. Gisselbrecht C, Oksenhendler E, Tirelli U, Lepage E, Gabarre J, Parcel JP, Gastaldi R, Coiffier B, Thyss A, Raphael M, et al: Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. French-Italian Cooperative Group. Am J Med 1993;95:188-196.
127. Lopez TM, Hagemeister FB, McLaughlin P, Velasquez WS, Swan F, Redman JR, Rodriguez MA, Tucker SL, Silvermintz K, Johnson J, et al: Small noncleaved cell lymphoma in adults: Superior results for stage I-III disease. J Clin Oncol 1990;8:615-622.
128. Coiffier B, Gisselbrecht C, Herbrecht R, Tilly H, Bosly A, Brousse N: LNH-84 regimen: A multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma. J Clin Oncol 1989;7:1018-1026.
129. Straus DJ, Wong GY, Liu J, Oppenberg J, Filippa DA, Gold JW, Offit K, Clarkson BD: Small non-cleaved-cell lymphoma (undifferentiated lymphoma, Burkitt's type) in American adults: Results with treatment designed for acute lymphoblastic leukemia. Am J Med 1991;90:328-337.
130. Leblond-Missenard V, Raphael M: Lymphomes après déficit constitutionnel ou acquis (en dehors du sida); in Sotal-Celigny P, Brousse N, Ferme C, Gisselbrecht C, Reyes F, Coiffier B (eds): Lymphomes. Paris, Frison-Roche, 1997, pp 319-324.
131. Harris KM, Schwartz ML, Slasky BS, Nalesnik M, Makowka L: Posttransplantation cyclosporine-induced lymphoproliferative disorders: Clinical and radiologic manifestations. Radiology 1987;162:697-700.
132. Armitage JM, Kormos RL, Stuart RS, Flicker FJ, Griffith BP, Nalesnik M, Hardesty RL, Dummer JS: Posttransplant lymphoproliferative disease in thoracic organ transplant patients: Ten years of cyclosporine-based immunosuppression. J Heart Lung Transplant 1991;10:877-886;886-887 (discussion).
133. Yousem SA, Randhawa P, Locker J, Paradis IL, Dauber JA, Griffith BP, Nalesnik MA: Posttransplant lymphoproliferative disorders in heart-lung transplant recipients: Primary presentation in the allograft. Hum Pathol 1989;20:361-369.
134. Hanto DW, Frizzera G, Gajl-Peczalska KJ, Sakamoto K, Purtilo DT, Balfour HH Jr, Simmons RL, Najarian JS: Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: Acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med 1982;306:913-918.
135. Starzle TE, Nalesnik MA, Porter KA, Ho M, Iwatsuki S, Griffith BP, Rosenthal JT, Hakala TR, Shaw BW Jr, Hardesty RL: Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1984;i:583-587.
136. Dodd GDd, Ledesma-Medina J, Baron RL, Fuhrman CR: Posttransplant lymphoproliferative disorder: Intrathoracic manifestations. Radiology 1992;184:65-96.
137. Rappaport DC, Chamberlain DW, Shepherd FA, Hutcheon MA: Lymphoproliferative disorders after lung transplantation: imaging features. Radiology 1998;206:519-524.
138. Leblond V, Sutton L, Dorent R, Davi F, Bitker MO, Gabarre J, Charlotte F, Ghoussoub JJ, Fourcadc C, Fischer A, et al: Lymphoproliferative disorders after organ transplantation: A report of 24 cases observed in a single center. J Clin Oncol 1995;13:961-968.
139. Hanto DW, Najarian JS: Advances in the diagnosis and treatment of EBV-associated lymphoproliferative diseases in immunocompromised hosts. J Surg Oncol 1985;30:215-220.
140. Pirsch JD, Stratta RJ, Sollinger HW, Hafez GR, D'Alessandro AM, Kalayoglu M, Belzer FO: Treatment of severe Epstein-Barr virus-induced lymphoproliferative syndrome with ganciclovir: Two cases after solid organ transplantation. Am J Med 1989;86:241-244.
141. Shapiro RS, Chauvenet A, McGuire W, Pearson A, Craft AW, McGlave P, Filipovich A: Treatment of B-cell lymphoproliferative disorders with interferon alfa and intravenous gamma globulin (letter). N Engl J Med 1988; 318:1334.
142. Fischer A, Blanche S, Le Bidois J, Bordigoni P, Gamier JL, N iaudet P, Morinet F, Le Deist F, Fischer AM, Griscelli C, et al: Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. N Engl J Med 1991;324:1451-1456.
143. Papadopoulos EB, Ladanyi M, Emanuel D, Mackinnon S, Boulad F, Carabasi MH, Castro-Malaspina H, Childs BH, Gillio AP, Small TN, et al: Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation (see comments). N Engl J Med 1994;330:1185-1191.
144. Heslop HE, Brenner MK, Rooney C, Krance RA, Roberts WM, Rochester R, Smith CA, Turner V, Sixbey J, Moen R, et al: Administration of neomycin-resistance-gene-marked EBV-specific cytotoxic T lymphocytes to recipients of mismatched-related or phenotypically similar unrelated donor marrow grafts. Hum Gene Ther 1994;5:381-397.
145. Heslop HE, Brenner MK, Rooney CM: Donor T cells to treat EBV-associated lymphoma (letter, comment). N Engl J Med 1994;331: 679-680.
146. Cleary ML, Warnke R, Sklar J: Monoclonality of lymphoproliferative lesions in cardiac-transplant recipients. Clonal analysis based on immunoglobulin-gene rearrangements. N Engl J Med 1984;310:477-482.
147. Randhawa PS, Yousem SA, Paradis IL, Dauber JA, Griffith BP, Locker J: The clinical spectrum, pathology, and clonal analysis of Epstein-Barr virus-associated lymphoproliferative disorders in heart-lung transplant recipients. Am J Clin Pathol 1989;92:177-185.
148. Andrieu JM, Roithmann S, Tourani JM, Levy R, Desablens B, le Maignan C, Gastaut JA, Brice P, Raphael M, Taillan B: Hodgkin's disease during HIV1 infection: The French registry experience. French Registry of HIV-associated Tumors. Ann Oncol 1993;4:635-641.
149. Ames ED, Conjalka MS, Goidberg AF, Hirschman R, Jain S, Distenfeld A, Metroka CE: Hodgkin's disease and AIDS. Twenty-three new cases and a review of the literature. Hematol Oncol Clin North Am 1991;5:343-356.
150. Gold JE, Altarac D, Ree HJ, Khan A, Sordillo PP, Zalusky R: HIV-associated Hodgkin's disease: A clinical study of 18 cases and review of the literature. Am J Hematol 1991; 36:93-99.
151. Ree HJ, Strauchen JA, Khan AA, Gold JE, Crowley JP, Kahn H, Zalusky R: Human immunodeficiency virus-associated Hodgkin's disease. Clinicopathologic studies of 24 cases and preponderance of mixed cellularity type characterized by the occurrence of fibro-histiocytoid stromal cells (see comments). Cancer 1991;67:1614-1621.
152. Rubio R: Hodgkin's disease associated with human immunodeficiency virus infection. A clinical study of 46 cases. Cooperative Study Group of Malignancies Associated with HIV Infection of Madrid. Cancer 1994;73:2400-2407.
153. Serrano M, Bellas C, Campo E, Ribera J, Martin C, Rubio R, Ruiz C, Ocana I, Buzon L, Yebra M, et al: Hodgkin's disease in patients with antibodies to human immunodeficiency virus. A study of 22 patients. Cancer 1990;65:2248-2254.
154. Tirelli U, Errante D, Dolcetti R, Gloghini A, Serraino D, Vaccher E, Franceschi S, Boiocchi M, Carbone A: Hodgkin's disease and human immunodeficiency virus infection: Clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors. J Clin Oncol 1995;13:1758-1767.
155. Roithmann S, Andrieu JM: Clinical and biological characteristics of malignant lymphomas in HIV-infected patients. Eur J Cancer 1992;28A:1501-1508.
156. Uccini S, Monardo F, Ruco LP, Baroni CD, Faggioni A, Agliano AM, Gradilone A, Manzari V, Vago L, Costanzi G, et al: High frequency of Epstein-Barr virus genome in HIV-positive patients with Hodgkin's disease (letter). Lancet 1989;i:1458.
157. Uccini S, Monardo F, Stoppacciaro A, Gradilone A, Agliano AM, Faggioni A, Manzari V, Vago L, Costanzi G, Ruco LP, et al: High frequency of Epstein-Barr virus genome detection in Hodgkin's disease of HIV-positive patients. Int J Cancer 1990;46:581-585.
158. Moran CA, Tuur S, Angritt P, Reid AH, O'Leary TJ: Epstein-Barr virus in Hodgkin's disease from patients with human immunodeficiency virus infection. Mod Pathol 1992; 5:85-88.
159. Audouin J, Diebold J, Pallesert G: Frequent expression of Epstein-Barr virus latent membrane protein-1 in tumour cells of Hodgkin's disease in HIV-positive patients. J Pathol 1992;167:381-384.
160. Lowenthal DA, Straus DJ, Campbell SW, Gold JW, Clarkson BD, Koziner B: AIDS-related lymphoid neoplasia. The Memorial Hospital experience. Cancer 1988;61:2325-2337.
161. Stern RG, Gamsu G, Golden JA, Hirji M, Webb WR, Abrams DI: Intrathoracic adenopathy: Differential feature of AIDS and diffuse lymphadenopathy syndrome. AJR 1984; 142:689-692.
162. Bacr DM, Anderson ET, Wilkinson LS: Acquired immune deficiency syndrome in homosexual men with Hodgkin's disease. Three case reports. Am J Med 1986;80:738-740.
163. Johnson BE, Linnoila RI, Williams JP, Venzon DJ, Okunieff P, Anderson GB, Richardson GE: Risk of second aerodigestive cancers increases in patients who survive free of small-cell lung cancer for more than 2 years. J Clin Oncol 1995;13:101-111.
164. Martini N, Melamed MR: Multiple primary lung cancers. J Thorac Cardiovasc Surg 1975; 70:606-612.
165. Van Meerbeeck J, Weyler J, Thibaut A, Van-steenkiste J, Aumann J, Deneffe G, Galdermans D, Haelterman M, Joos G, Noppen M, Pinson P, Tasson J, van den Eeckhout A, Uydebrouck M: Second primary lung cancer in Flanders: Frequency, clinical presentation, treatment and prognosis. Lung Cancer 1996; 15:281-295.
166. Thomas PA Jr, Rubinstein L: Malignant disease appearing late after operation for T1 N0 non-small-cell lung cancer. The Lung Cancer Study Group. J Thorac Cardiovasc Surg 1993;106:1053-1058.
167. Martini N, Bains MS, Burt ME, Zakowski MF, McCormack P, Rusch VW, Ginsberg RJ: Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995;109:120-129.
168. Razzuk MA, Pockey M, Urschel HC Jr, Paulson DL: Dual primary bronchogenic carcinoma. Ann Thorac Surg 1974;17:425-433.
169. Tockman MS, Mulshine JL, Piantadosi S, Erozan YS, Gupta PK, Ruckdeschel JC, Taylor PR, Zhukov T, Zhou WH, Qiao YL, Yao SX: Prospective detection of preclinical lung cancer: Results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression. Clin Cancer Res 1997;3:2237-2246.
170. Ginsberg RJ, Rubinstein LV: Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995;60: 615-622; 622-623 (discussion).
171. Antakli T, Schaefer RF, Rutherford JE, Read RC: Second primary lung cancer. Ann Thorac Surg 1995;59:863-867.
172. Pairolero PC, Williams DE, Bergstralh EJ, Piehler JM, Bernatz PE, Payne WS: Postsurgical stage I bronchogenic carcinoma: Morbid implications of recurrent disease. Ann Thorac Surg 1984;38:331-338.
173. Pastorino U, Infante M, Maioli M, Chiesa G, Buyse M, Firket P, Rosmentz N, Clerici M, Soresi E, Valente M, et al: Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J Clin Oncol 1993;11:1216-1222.
174. Saito Y, Sato M, Sagawa M, Kanma K, Takahashi S, Usuda K, Nagamoto N, Endo C, Chen Y, Sakurada A, et al: Multicentricity in resected occult bronchogenic squamous cell carcinoma. Ann Thorac Surg 1994;57:1200-1205.
175. Ribet M, Dambron P: Multiple primary lung cancers. Eur J Cardiothorac Surg 1995;9: 231-236.
176. Salerno TA, Munro DD, Blundell PE, Chiu RC: Second primary bronchogenic carcinoma: Life-table analysis of surgical treatment. Ann Thorac Surg 1979;27:3-6.
177. Sugimura H, Watanabe S, Tsugane S, Morinaga S, Yoneyama T: Case-control study on histologically determined multiple primary lung cancer. J Natl Cancer Inst 1987;79:435-441.
178. Verhagen AF, Tavilla G, van de Wal HJ, Cox AL, Lacquet LK: Multiple primary lung cancers. Thorac Cardiovasc Surg 1994;42:40-44.
179. Deschamps C, Pairolero PC, Trastek VF, Payne WS: Multiple primary lung cancers. Results of surgical treatment. J Thorac Cardiovasc Surg 1990;99:769-778.
180. Rosengart TK, Martini N, Ghosn P, Burt M: Multiple primary lung carcinomas: Prognosis and treatment. Ann Thorac Surg 1991;52: 773-778; 778-779 (discussion).
181. Wu SC, Lin ZQ, Xu CW, Koo KS, Huang OL, Xie DQ: Multiple primary lung cancers. Chest 1987;92:892-896.
182. Mathisen DJ, Jensik RJ, Faber LP, Kittle CF: Survival following resection for second and third primary lung cancers. J Thorac Cardiovasc Surg 1984;88:502-510.
183. Neptune WB, Woods FM, Overholt RH: Reoperation for bronchogenic carcinoma. J Thorac Cardiovasc Surg 1966;52:342-350.
184. Fleisher AG, McElvaney G, Robinson CL: Multiple primary bronchogenic carcinomas: Treatment and follow-up. Ann Thorac Surg 1991;51:48-51.
185. Angeletti CA, Mussi A, Janni A, Lucchi M, Ribechini A, Chella A, Fontanini G: Second primary lung cancer and relapse: Treatment and follow-up. Eur J Cardiothorac Surg 1995; 9:607-611.
186. Faber LP: Resection for second and third primary lung cancer. Semin Surg Oncol 1993;9: 135-141.
187. Watanabe Y, Shimizu J, Oda M, Tatsuzawa Y, Hayashi Y, Iwa T: Second surgical intervention for recurrent and second primary bronchogenic carcinomas. Scand J Thorac Cardiovasc Surg 1992;26:73-78.
188. Tucker MA, Murray N, Shaw EG, Ettinger DS, Mabry M, Huber MH, Feld R, Shepherd FA, Johnson DH, Grant SC, Aisner J, Johnson BE: Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working Cadre (see comments). J Natl Cancer Inst 1997;89:1782-1788.
189. Sagman U, Lishner M, Maki E, Shepherd FA, Haddad R, Evans WK, DeBoer G, Payne D, Pringle JF, Yeoh JL, et at: Second primary malignancies following diagnosis of small-cell lung cancer. J Clin Oncol 1992;10:1525-1533.
190. Richardson GE, Tucker MA, Venzon DJ, Linnoila RI, Phelps R, Phares JC, Edison M, Ihde DC, Johnson BE: Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Ann Intern Med 1993;119:383-390.
191. Johnson BE, Ihde DC, Matthews MJ, Bunn PA, Zabell A, Makuch RW, Johnston-Early A, Cohen MH, Glatstein E, Minna JD: Non-small-cell lung cancer. Major cause of late mortality in patients with small cell lung cancer. Am J Med 1986;80:1103-1110.
192. Szczepek B, Szymanska D, Decker E, Wasowska H, Slupek A, Rowinska-Zakrzewska E: Risk of late recurrence and/or second lung cancer after treatment of patients with small cell lung cancer (SCLC). Lung Cancer 1994; 11:93-104.
193. Heyne KH, Lippman SM, Lee JJ, Lee JS, Hong WK: The incidence of second primary tumors in long-term survivors of small-cell lung cancer (see comments). J Clin Oncol 1992;10:1519-1524.
194. Johnson BE, Cortazar P, Chute JP: Second lung cancers in patients successfully treated for lung cancer. Semin Oncol 1997;24:492-499.
195. Lassen U, Osterlind K, Hansen M, Dombernowsky P, Bergman B, Hansen HH: Long-term survival in small-cell lung cancer: Post-treatment characteristics in patients surviving 5 to 18+ years - an analysis of 1,714 consecutive patients. J Clin Oncol 1995;13: 1215-1220.
196. Sekine I, Nishiwaki Y, Kakinuma R, Kubota K, Hojo F, Matsumoto T, Ohmatsu H, Yokozaki M, Goto K, Kodama T: Late recurrence of small-cell lung cancer: Treatment and outcome. Oncology 1996;53:318-321.
197. Pignon JP, Arriagada R, Ihde DC, Johnson DH, Perry MC, Souhami RL, Brodin O, Joss RA, Kies MS, Lebeau B, et al: A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 1992;327:1618-1624.
198. Warde P, Payne D: Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol 1992;10:890-895.
199. Kaldor JM, Day NE, Bell J, Clarke EA, Langmark F, Karjalainen S, Band P, Pedersen D, Choi W, Blair V, et al: Lung cancer following Hodgkin's disease: A case-control study. Int J Cancer 1992;52:677-681.
200. Abrahamsen JF, Andersen A, Hannisdal E, Nome O, Abrahamsen AF, Kvaloy S, Host H: Second malignancies after treatment of Hodgkin's disease: The influence of treatment, follow-up time, and age. J Clin Oncol 1993;11:255-261.
201. Swerdlow AJ, Douglas AJ, Hudson GV, Hudson BV, Bennett MH, MacLennan KA: Risk of second primary cancers after Hodgkin's disease by type of treatment: Analysis of 2846 patients in the British National Lymphoma Investigation. BMJ 1992;304:1137-1143.
202. Swerdlow AJ, Barber JA, Horwich A, Cunningham D, Milan S, Omar RZ: Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital. Br J Cancer 1997;75:116-123.
203. Tucker MA, Coleman CN, Cox RS, Varghese A, Rosenberg SA: Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med 1988;318:76-81.
204. van Leeuwen FE, KJokman WJ, Hagenbeek A, Noyon R, van den Belt-Dusebout AW, van Kerkhoff EH, van Heerde P, Somers R: Second cancer risk following Hodgkin's disease: A 20-year follow-up study. J Clin Oncol 1994; 12:312-325.
205. Neugut AI, Murray T, Santos J, Amols H, Hayes MK, Flannery JT, Robinson E: Increased risk of lung cancer after breast cancer radiation therapy in cigarette smokers (see comments). Cancer 1994;73:1615-1620.
206. Inskip PD, Stovall M, Flannery JT: Lung cancer risk and radiation dose among women treated for breast cancer. J Natl Cancer Inst 1994;86:983-988.
207. van Leeuwen FE, Klokman WJ, Stovall M, Hagenbeek A, van den Belt-Dusebout AW, Noyon R, Boice JD, Jr, Burgers JM, Somers R: Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease. J Natl Cancer Inst 1995;87:1530-1537.
208. Taniguchi S, Cooper DK, Chaffin JS, Zuhdi N: Primary bronchogenic carcinoma in recipients of heart transplants. Transplant Int 1997;10:312-316.
209. Couetil JP, McGoldrick JP, Wallwork J, English TA: Malignant tumors after heart transplantation. J Heart Transplant 1990;9:622-626.
210. Fleming RH, Jennison SH, Naunheim KS: Primary bronchogenic carcinoma in the heart transplant recipient. Ann Thorac Surg 1994; 57:1300-1301.
211. Pham SM, Kormos RL, Landreneau RJ, Kawai A, Gonzalez-Cancel I, Hardesty RL, Hattler BG, Griffith BP: Solid tumors after heart transplantation: Lethality of lung cancer. Ann Thorac Surg 1995;60:1623-1626.
212. Penn I: Tumors after renal and cardiac transplantation. Hematol Oncol Clin North Am 1993;7:431-445.
213. Goldstein DJ, Austin JH, Zuech N, Williams DL, Stoopler MB, Michler RE, Schulman LL: Carcinoma of the lung after heart transplantation. Transplantation 1996;62:772-775.
214. Nabel GJ: A transformed view of cyclosporine. Nature 1999;397:471-472.
215. Irwin LE, Begandy MK, Moore TM: Adenosquamous carcinoma of the lung and the acquired immunodeficiency syndrome (letter). Ann Intern Med 1984;100:158.
216. Biggar RJ, Burnett W, Mikl J, Nasca P: Cancer among New York men at risk of acquired immunodeficiency syndrome. Int J Cancer 1989;43:979-985.
217. Chan TK, Aranda CP, Rom WN: Bronchogenic carcinoma in young patients at risk for acquired immunodeficiency syndrome. Chest 1993;103:862-864.
218. Monfardini S, Vaccher E, Pizzocaro G, Stellini R, Sinicco A, Sabbatani S, Marangolo M, Zagni R, Clerici M, Foa R, et al: Unusual malignant tumours in 49 patients with HIV infection. AIDS 1989;3:449-452.
219. Reynolds P, Saunders LD, Layefsky ME, Lemp GF: The spectrum of acquired immunodeficiency syndrome (AIDS)-associated malignancies in San Francisco, 1980-1987. Am J Epidemiol 1993;137:19-30.
220. Braun MA, Killam DA, Remick SC, Ruckdeschel JC: Lung cancer in patients seropositive for human immunodeficiency virus. Radiology 1990;175:341-343.
221. Parker MS, Leveno DM, Campbell TJ, Worrell JA, Carozza SE: AIDS-related bronchogenie carcinoma: Fact or fiction? Chest 1998; 113:154-161.
222. Johnson CC, Wilcosky T, Kvale P, Rosen M, Stansell J, Glassroth J, Reichman L, Wallace J, Markowitz N, Thompson JE, Hopewell P: Cancer incidence among an HIV-infected cohort. Pulmonary Complicationsof HIV Infection Study Group. Am J Epidemiol 1997;146: 470-475.
223. Fraire AE, Awe RJ: Lung cancer in association with human immunodeficiency virus infection. Cancer 1992;70:432-436.
224. Sridhar KS, Flores MR, Raub WA Jr, Saldana M: Lung cancer in patients with human immunodeficiency virus infection compared with historic control subjects (see comments). Chest 1992;102:1704-1708.
225. Ramalingam S, Pawlish K, Gadgeel S, Demers R, Kalemkerian GP: Lung cancer in young patients: Analysis of a Surveillance, Epidemiology, and End Results Database. J Clin Oncol 1998;16:651-657.
226. Rook AH, Masur H, Lane HC, Frederick W, Kasahara T, Macher AM, Djeu JY, Manischewitz JF, Jackson L, Fauci AS, Quinnan GV Jr: Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome. J Clin Invest 1983;72:398-403.
227. Nguyen VQ, Ossorio MA, Roy TM: Bronchogenic carcinoma and the acquired immunodeficiency syndrome. J Ky Med Assoc 1991;89:322-324.
228. Ferrozzi F, Campodonico F, Bova D, De Chiara F, Menozzi R, Marenzi C, Viani S, Pizzaferri P, Pan A, Bassi P: AIDS-related neoplasms: A clinico-radiological study. Radiol Med 1996;91:434-439.
229. Vaccher E, Tirelli U, Spina M, Errante D, Crosato I, Sabbatani S, Sinicco A, Monfardini S: Lung cancer in 19 patients with HIV infection. The Italian Cooperative Study Group on AIDS and Tumors (GICAT) (letter). Ann Oncol 1993;4:85-86.
230. Karp J, Profeta G, Marantz PR, Karpel JP: Lung cancer in patients with immunodeficiency syndrome. Chest 1993;103:410-413.
231. Fishman JE, Schwartz DS, Sais GJ, Flores MR, Sridhar KS: Bronchogenic carcinoma in HIV-positive patients: Findings on chest radiographs and CT scans. AJR 1995;164:57-61.